Sanofi enters into a €2 billion share buyback mandate

On February 7, 2025, Sanofi announced the signing of a mandate to buy back its own shares for up to €2 billion. This program is part of a global €5 billion initiative planned for 2025. The company has already completed a first tranche, amounting to €3 billion, via a block transaction with L'Oréal.

The new mandate, entered into with an investment services provider, will run from February 7 to December 31, 2025. Sanofi's primary objective is to cancel the repurchased shares. This strategy could have implications for the company's capital structure, potentially resulting in a reduction in the number of shares outstanding.